Park A - Search Results

1

In vitro and in vivo evaluation of a non-carbohydrate targeting platform for lysosomal proteins.

Stefano JE, Hou L, Honey D, Kyazike J, Park A, Zhou Q, Pan CQ, Edmunds T. Stefano JE, et al. Among authors: park a. J Control Release. 2009 Apr 17;135(2):113-8. doi: 10.1016/j.jconrel.2008.12.006. Epub 2008 Dec 24. J Control Release. 2009. PMID: 19146893

2

Carbohydrate-mediated polyethylene glycol conjugation of TSH improves its pharmacological properties.

Park A, Honey DM, Hou L, Bird JJ, Zarazinski C, Searles M, Braithwaite C, Kingsbury JS, Kyazike J, Culm-Merdek K, Greene B, Stefano JE, Qiu H, McPherson JM, Pan CQ. Park A, et al. Endocrinology. 2013 Mar;154(3):1373-83. doi: 10.1210/en.2012-2010. Epub 2013 Feb 6. Endocrinology. 2013. PMID: 23389953

3

Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function.

Zhou Q, Shankara S, Roy A, Qiu H, Estes S, McVie-Wylie A, Culm-Merdek K, Park A, Pan C, Edmunds T. Zhou Q, et al. Among authors: park a. Biotechnol Bioeng. 2008 Feb 15;99(3):652-65. doi: 10.1002/bit.21598. Biotechnol Bioeng. 2008. PMID: 17680659

4

Micro- and mid-scale maleimide-based conjugation of cytotoxic drugs to antibody hinge region thiols for tumor targeting.

Stefano JE, Busch M, Hou L, Park A, Gianolio DA. Stefano JE, et al. Among authors: park a. Methods Mol Biol. 2013;1045:145-71. doi: 10.1007/978-1-62703-541-5_9. Methods Mol Biol. 2013. PMID: 23913146

5

Impact of cysteine variants on the structure, activity, and stability of recombinant human α-galactosidase A.

Qiu H, Honey DM, Kingsbury JS, Park A, Boudanova E, Wei RR, Pan CQ, Edmunds T. Qiu H, et al. Among authors: park a. Protein Sci. 2015 Sep;24(9):1401-11. doi: 10.1002/pro.2719. Epub 2015 Jul 14. Protein Sci. 2015. PMID: 26044846 Free PMC article.

6

Site-specific PEGylation of human thyroid stimulating hormone to prolong duration of action.

Qiu H, Boudanova E, Park A, Bird JJ, Honey DM, Zarazinski C, Greene B, Kingsbury JS, Boucher S, Pollock J, McPherson JM, Pan CQ. Qiu H, et al. Among authors: park a. Bioconjug Chem. 2013 Mar 20;24(3):408-18. doi: 10.1021/bc300519h. Epub 2013 Feb 11. Bioconjug Chem. 2013. PMID: 23350694

7

Site-specific antibody-drug conjugation through glycoengineering.

Zhou Q, Stefano JE, Manning C, Kyazike J, Chen B, Gianolio DA, Park A, Busch M, Bird J, Zheng X, Simonds-Mannes H, Kim J, Gregory RC, Miller RJ, Brondyk WH, Dhal PK, Pan CQ. Zhou Q, et al. Among authors: park a. Bioconjug Chem. 2014 Mar 19;25(3):510-20. doi: 10.1021/bc400505q. Epub 2014 Feb 28. Bioconjug Chem. 2014. PMID: 24533768

8

Site-Specific Antibody Conjugation to Engineered Double Cysteine Residues.

Zhou Q, Kyazike J, Boudanova E, Drzyzga M, Honey D, Cost R, Hou L, Duffieux F, Brun MP, Park A, Qiu H. Zhou Q, et al. Among authors: park a. Pharmaceuticals (Basel). 2021 Jul 14;14(7):672. doi: 10.3390/ph14070672. Pharmaceuticals (Basel). 2021. PMID: 34358098 Free PMC article.

9

Engineered Fc-glycosylation switch to eliminate antibody effector function.

Zhou Q, Jaworski J, Zhou Y, Valente D, Cotton J, Honey D, Boudanova E, Beninga J, Rao E, Wei R, Mauriac C, Pan C, Park A, Qiu H. Zhou Q, et al. Among authors: park a. MAbs. 2020 Jan-Dec;12(1):1814583. doi: 10.1080/19420862.2020.1814583. MAbs. 2020. PMID: 32892677 Free PMC article.

10

Structure-based engineering to restore high affinity binding of an isoform-selective anti-TGFβ1 antibody.

Lord DM, Bird JJ, Honey DM, Best A, Park A, Wei RR, Qiu H. Lord DM, et al. Among authors: park a. MAbs. 2018 Apr;10(3):444-452. doi: 10.1080/19420862.2018.1426421. Epub 2018 Feb 1. MAbs. 2018. PMID: 29333938 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,781 results

Search Page